Pacira Pharmaceuticals, Inc. Business Operations Contracts & Agreements
32 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Distribution Agreements (4)
- Indemnification Agreements (2)
- Marketing Agreements (4)
- Sales Agreements (2)
- Services Agreements (9)
- Supply Agreements (10)
- Third Amendment to Manufacturing and Supply Agreement dated December 1, 2023, by and between the Registrant and Patheon UK Limited (Filed With SEC on February 29, 2024)
- Second Amendment to Manufacturing and Supply Agreement dated June 17, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Filed With SEC on February 29, 2024)
- First Amendment to Manufacturing and Supply Agreement dated May 8, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Filed With SEC on February 29, 2024)
- Commercial Outsourcing Services Agreement entered into as of February 26, 2024 by the Registrant and Integrated Commercialization Solutions, Inc (Filed With SEC on February 29, 2024)
- Form of Indemnification Agreement between the Registrant and its directors and officers (Filed With SEC on February 29, 2024)
- Side Letter dated June 5, 2023, to the Manufacturing and Supply Agreement by and between the Registrant and Patheon UK Limited (Filed With SEC on August 2, 2023)
- Side Letter to the Manufacturing and Supply Agreement between Flexion Therapeutics, Inc. and Patheon UK Limited, dated as of April 8, 2020 (Filed With SEC on February 28, 2022)
- Technical Transfer and Service Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)
- Manufacturing and Supply Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)
- Fourth through Eleventh Amendments to Commercial Outsourcing Services Agreement, between the Registrant and Integrated Commercialization Solutions, Inc (Filed With SEC on May 7, 2020)
- Second Amendment to Co-Promotion Agreement, dated December 21, 2018, between the Registrant and DePuy Synthes Sales, Inc (Filed With SEC on February 28, 2019)
- First Amendment to Co-Promotion Agreement, dated April 19, 2018, between the Registrant and DePuy Synthes Sales, Inc (Filed With SEC on May 3, 2018)
- AMENDMENT #5 TO SERVICES AGREEMENT (Filed With SEC on April 30, 2015)
- AMENDMENT #4 TO SERVICES AGREEMENT (Filed With SEC on April 30, 2015)
- AMENDMENT #3 TO SERVICES AGREEMENT (Filed With SEC on October 31, 2013)
- AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on December 9, 2011)
- PACIRA PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on January 13, 2011)
- DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Filed With SEC on January 13, 2011)
- AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on January 13, 2011)
- DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Filed With SEC on January 13, 2011)
- DATED July 27, 2005 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT (Depocyte - Additional Territories) 1 (Filed With SEC on January 13, 2011)
- DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT 1 (Filed With SEC on January 13, 2011)
- PACIRA PHARMACEUTICALS, INC. Stack Pharmaceuticals, Inc. Services Agreement (Filed With SEC on December 3, 2010)
- SERVICES AGREEMENT (Filed With SEC on December 3, 2010)
- SUPPLY AGREEMENT (Filed With SEC on December 3, 2010)
- DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Filed With SEC on December 3, 2010)
- AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on December 3, 2010)
- DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Filed With SEC on December 3, 2010)
- DEPOCYT® SUPPLY AND DISTRIBUTION AGREEMENT BY AND BETWEEN SKYEPHARMA, INC. AND ENZON PHARMACEUTICALS, INC. DATED AS OF DECEMBER 31, 2002 TABLE OF CONTENTS (Filed With SEC on December 3, 2010)
- CO-DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN ENZON PHARMACEUTICALS, INC. AND JAGOTEC, AG, SKYEPHARMA,INC., AND SKYEPHARMA PLC DATEDAS OF JANUARY 2, 2003... (Filed With SEC on December 3, 2010)
- DATED July 27, 2005 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT (Depocyte - Additional Territories) 1 (Filed With SEC on December 3, 2010)
- DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT 1 (Filed With SEC on December 3, 2010)
